Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Bend strength of alumina ceramics: A comparison of Weibull statistics with other statistics based on very large experimental data set
Bend-Induced Brillouin Frequency Shift Variation in a Single-Mode Fiber
Bending and Twisting of Suspended Single-Walled Carbon Nanotubes in Solution
Bending-induced optical loss in random-hole optical fibers
Bending the Arc of the Health Care Universe Through Systems Improvement
Bend-insensitive ultra short long-period gratings by the electric arc method and their applications to harsh environment sensing and communication
Bend sensing by measuring the resonance splitting of long-period fiber gratings
Bending kinetics of a photo-actuating nematic elastomer cantilever
Bending and flexural phonon scattering: Generalized Dirac equation for an electron moving in curved graphene
Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block
Bending Effect of sp-Hybridized Carbon (Carbyne) Chains on Their Structures and Properties
Bending of metal-filled carbon nanotube under electron beam irradiation
Bendability of advanced high strength steels-A new evaluation procedure
Bending Response of Cross-Ply Laminated Composite Plates with Diagonally Perturbed Localized Interfacial Degeneration
Bending and buckling of rolled-up SiGe/Si microtubes using nanorobotic manipulation
Bending Instability of a General Cross Section Thin-Wall Tube for Minimal Radius of Curvature Passage
Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro
Bending Efficiency of Bent Multiple-Slot Waveguides
Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma
Bendamustine: Rebirth of an Old Drug
Bendamustine therapy in chronic lymphocytic leukemia
Bending of electromagnetic wave in an ultra-strong magnetic field
Bending a beamby a generalized ideal elastomeric gel
Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
Bend loss in multimode chalcogenide fiber at infrared wavelengths
Bending AdS waves with new massive gravity
Bending lipid membranes: Experiments after W. Helfrich's model
Bending and free vibration analysis of functionally graded sandwich plates using the Refined Zigzag Theory
Bending the rules: Contrasting vacancy energetics and migration in graphite and carbon nanotubes
Benders Decomposition for multi-stage stochastic mixed complementarity problems - Applied to a global natural gas market model (vol 226, pg 341, 2013)
Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data
Bending Rigid Molecular Rods: Formation of Oligoproline Macrocycles
Bendamustine in chronic lymphocytic leukemia: the future is combination therapy
Bending analysis of simply supported shear deformable skew plates
Bending solution for thick plates with quadrangular boundary
Bending analysis of moderately thick laminated conical panels with various boundary conditions
Bendamustine: Rescue of an Effective Antineoplastic Agent From the Mid-Twentieth Century
Bendamustine Therapy in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin%26apos;s lymphoma patients A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)
Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma
Bendamustine in chronic lymphocytic leukemia and refractory lymphoma
Bendamustine
Bendamustine in Metastatic Breast Cancer: An Old Drug in New Design
Bendamustine A Review of its Use in the Management of Indolent Non-Hodgkin Lymphoma
Bendamustine in the treatment of non-Hodgkin's lymphomas
Bendamustine (Treanda) for CLL and NHL
Bendamustine Is Effective in p53-Deficient B-Cell Neoplasms and Requires Oxidative Stress and Caspase-Independent Signaling
Bendamustine: A Novel Cytotoxic Agent for Hematologic Malignancies
Bendamustine A New Look at an Old Drug
Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma